FibroGen (FGEN) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 3.95 | 1.11 | 1.06 | 1.17 | 0.25 | 1.24 | |||
Changes by years, y/y, % | -57% | -72% | -5% | +11% | -79% | -48.6% |
FibroGen. Debt/EBITDA
FibroGen. Debt/EBITDA, changes, %
FibroGen (FGEN) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 0.35 | 0.25 | 0.04 | -0.16 | 1.24 | 1.24 | ||
Changes by years, y/y, % | -60% | -79% | -95% | -128% | +250% | |||
Changes by quarters, q/q, % | -39% | -30% | -83% | -486% | -874% |